GLUCOSE HEALTH, INC.
GLUCOSE HEALTH, INC.
BENTONVILLE, AR
Loading...
Price History
Market Data
| Market Cap | 1.30M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 0.06 |
| Currency | USD |
Key Financial Metrics
88,130.00
Revenue
-85,062.00
Net Income
-
EPS (Diluted)
-41,016.00
Free Cash Flow
Profitability
Gross Margin
65.4%
Operating Margin
-36.8%
Net Profit Margin
-96.5%
EBITDA
-32,449.00
Returns & Efficiency
Return on Assets (ROA)
-322.8%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-
Financial Health
Total Assets
26,353.00
Total Debt
-
Debt to Equity
-
Current Ratio
0.06
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | BENTONVILLE, AR |
| Fiscal Year | 2016 |
Peers
TRULIEVE CANNABIS CORP.
TCNNF
2.31B
P/E: --
CRONOS GROUP INC.
CRON
1.44B
P/E: --
TILRAY, INC.
TLRY
682.34M
P/E: --
TILRAY BRANDS, INC.
TLRY
682.34M
P/E: --
Tilray Brands, Inc.
TLRY
682.34M
P/E: --
654.42M
P/E: --
CHROMADEX CORP.
NAGE
383.49M
P/E: 21.0
383.49M
P/E: 21.0
Quick Links
Financial Statistics
Valuation
Market Cap$1.30M
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin65.4%
Operating Margin-36.8%
Net Margin-96.5%
ROE-
ROA-322.8%
Leverage & Liquidity
Debt to Equity-
Current Ratio0.06
Total Debt-
Total Assets$26.35K
Stockholders' Equity$-426.23K
Income Statement (FY 2016)
Revenue$88.13K
Gross Profit$57.63K
Operating Income$-32.45K
Net Income$-85.06K
EPS (Diluted)-
Cash Flow (FY 2016)
Free Cash Flow$-41.02K
Cash & Equivalents$16.64K
Revenue Growth-71.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 609 SW 8TH STREET, SUITE 600 BENTONVILLE, AR 72712 |
| Phone | 479-802-3827 |
| Incorporated | NV, US |
| EIN | 901117742 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 4.15M |
| Stockholders' Equity | $-426.23K |
| Cash & Equivalents | $16.64K |
Recent Filings
View All
D
D Filing
SEC regulatory filing
Filed: 2026-02-04
D
D Filing
SEC regulatory filing
Filed: 2025-12-05
D/A
D/A Filing
SEC regulatory filing
Filed: 2024-01-19
D
D Filing
SEC regulatory filing
Filed: 2023-12-07
RW
Registration Withdrawal
Request for withdrawal of registration
Filed: 2023-06-28
S-1/A
Amended IPO Registration
Amendment to IPO registration statement
Filed: 2023-01-09
View
S-1/A
Amended IPO Registration
Amendment to IPO registration statement
Filed: 2022-09-06
View
S-1/A
Amended IPO Registration
Amendment to IPO registration statement
Filed: 2022-08-05
View
S-1
IPO Registration
Registration statement for initial public offering
Filed: 2022-06-01
View
D
D Filing
SEC regulatory filing
Filed: 2021-03-09
D
D Filing
SEC regulatory filing
Filed: 2020-06-19
D
D Filing
SEC regulatory filing
Filed: 2020-05-12
D
D Filing
SEC regulatory filing
Filed: 2019-05-03
15-12G
Deregistration (12g)
Certification of termination of registration under 12(g)
Filed: 2018-04-16
NT 10-K
Late Filing Notice (10-K)
2017-12-31 • Notification of late annual report filing
Filed: 2018-04-02
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | GLUCOSE HEALTH, INC. |
| Ticker | GLUC |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | BENTONVILLE, AR |
| Fiscal Year | 2016 |
Financial Summary
| Market Cap | 1.30M |
| Revenue | 88,130.00 |
| Net Income | -85,062.00 |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -96.5% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...